These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


242 related items for PubMed ID: 1511919

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Radiotherapy of Hodgkin's disease].
    Patrício MB.
    Acta Med Port; 1990; 3(1):11-3. PubMed ID: 1692179
    [Abstract] [Full Text] [Related]

  • 23. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Olweny CL, Ziegler JL.
    N Engl J Med; 2008 Feb 14; 358(7):742; author reply 743. PubMed ID: 18272899
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Hodgkin's disease in children. Current therapeutic strategies].
    Oberlin O, Habrand JL, Schaison G, Leverger G, Zucker JM, Olive D, Lemerle J.
    Bull Cancer; 1988 Feb 14; 75(1):53-60. PubMed ID: 2451953
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
    Baĭsogolov GD, Afanasova NV, Shakhtarina SV.
    Med Radiol (Mosk); 1990 May 14; 35(5):10-3. PubMed ID: 2342405
    [No Abstract] [Full Text] [Related]

  • 31. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P, Abate G, Fiore M, Di Finizio G, Frezza P, Scoppa G, Anania C, Coucourde F, Zarrilli D.
    J Chemother; 1989 Jul 14; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Improved survival rates in Hodgkin's disease].
    Hayabuchi N, Jingu K, Miyoshi M, Hirata H, Masuda K, Shibuya T, Nishimura J, Komiyama S, Ishii E, Kikuchi M.
    Gan No Rinsho; 1988 Apr 14; 34(5):698-704. PubMed ID: 2455073
    [Abstract] [Full Text] [Related]

  • 34. [Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases].
    Zandecki M, Dupriez B, Laï JL, Fenaux P, Facon T, Lepelley P, Estienne MH, Huart JJ, Jouet JP.
    Nouv Rev Fr Hematol (1978); 1987 Apr 14; 29(6):365-9. PubMed ID: 3330607
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hodgkin's disease: controversies and challenges for the future.
    Tura S, Canellos G, Goldstone A, Longo D, McMillan A, Urba W, Zinzani PL.
    Haematologica; 1991 Apr 14; 76(4):263-79. PubMed ID: 1724436
    [No Abstract] [Full Text] [Related]

  • 39. [Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
    Lira P, Grebe G.
    Rev Med Chil; 1984 Oct 14; 112(10):1021-5. PubMed ID: 6085597
    [No Abstract] [Full Text] [Related]

  • 40. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
    Fiacchini M, Lauria F, Mazza P, Cantore M, Gherlinzoni F, Tura S.
    Haematologica; 1985 Oct 14; 70(2):148-54. PubMed ID: 3924778
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.